Anti-Human sRANKL

Leinco Technologies
Product Code: LEI-R139
Product Group: Primary Antibodies
CodeSizePrice
LEI-R139-100ug100 ug£542.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody should be stored desiccated at -20°C. The reconstituted antibody can be stored for at least six weeks at 4°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Further Information

Conjugate/Tag/Label:
Antigen Affinity Purified
Format:
This antigen affinity purified polyclonal antibody is aseptically filtered and lyophilized from PBS with no carrier proteins or preservatives added.
Formulation:
This antigen affinity purified polyclonal antibody is aseptically filtered and lyophilized from PBS with no carrier proteins or preservatives added.
Immunogen:
Purified Recombinant sRANKL (>98%)
Long Description:
RANKL (Receptor Activator for Nuclear Factor κ B Ligand), also known as TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and ODF (osteoclast differentiation factor), is a member of the tumor necrosis factor family cytokine.1 RANKL is essential for osteoclast formation, activation, and survival.2 RANKL through interaction with its receptor RANK can modulate matrix degradation and inflammation.3 RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy. Consequently, novel drugs specifically targeting RANK, RANKL, and their signaling pathways in osteoclasts are expected to revolutionize the treatment of various ailments associated with bone loss, such as arthritis, periodontal disease, cancer metastases, and osteoporosis.4
NCBI Gene:
8600
Target:
sRANKL

References

1. H Takayanagi et al. (2003) Arthritis Res Ther. 5: 20 2. Kostenuik PJ et al. (2005) Endocrinology 146: 3235 3. Holven KB et al. (2009) Stroke 40: 241 4. Penninger JM et al. (2008) Ann N Y Acad Sci. 1143: 123

Related Products

Product NameProduct CodeSupplier 
Anti-Mouse sRANKL - BiotinLEI-R1145Leinco Technologies Summary Details
RANKL Blocking PeptideLEI-R1243Leinco Technologies Summary Details